Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
39 Cards in this Set
- Front
- Back
RSV causes (disease) in (population) |
bronchiolitis; in infants (especially neonates) |
|
rhinovirus causes what common disease? |
THE COMMON COLD |
|
Adenovirus causes what diseases? |
mostly RTI; also gastro, keratoconjunctivitis |
|
Adenovirus causes infection by what age? |
Usually 14 |
|
Coronavirus causes what sort of disease |
URTI, pneumonia |
|
Some examples of Coronaviruses |
SARS; MERS |
|
Symptoms caused by Influenza viruses |
fever, myalgia, HA, cough |
|
RNA viruses usually cause _______ disease |
ACUTE; no latency |
|
DNA viruses usually cause _______ disease |
latency; integrate with host DNA |
|
Viruses spread by droplet/aerosol |
RSV; adenovirus; rhinovirus; coronavirus; influenza; (ie, ones causing respiratory disease); also VZV |
|
Viruses spread by fecal-oral transmission |
Adenovirus; norovirus; (rotavirus?); Enteroviruses |
|
Viruses which are sexually transmitted (transmucosal/direct contact) |
HSV; CMV; EBV (herpesviridae) |
|
Viruses spread by zoonosis/animal vectors |
Ebola (fruit bats); Dengue (Aedes mosquitos); Rabies (animal saliva, bat caves) |
|
Rotavirus causes _______ in _______ populations |
vomiting/watery diarrhea; in infants/children |
|
Norovirus causes ________ in __________ populations |
vomiting/watery diarrhea; in adults & schoolchildren |
|
First incidence of Dengue infection causes... |
"bone break fever" |
|
Second incidence of Dengue infection causes... |
hemorrhagic fever |
|
Adamantane/Amantadine drug target virus |
Influenza A only |
|
Tamiflu/Zanamivir drug target virus |
Influenza A AND B |
|
Adamantane/Amantadine drug resistance prevalence |
up to 30%; almost all current strains resistant |
|
Oseltamivir/Tamiflu drug resistance prevalence |
infrequent; unrelated to Zanamivir resistance (since requires conformational change of neuraminidase) |
|
Side effects of Oseltamivir/Zanamivir |
GI upset |
|
Principles/goals of Oseltamivir treatment |
Treat early; within 48 hours of detection to prevent worsening (this is peak of viral replication) |
|
Adamantane/Amantadine administration & age |
oral; >1year |
|
Oseltamivir administration & age |
oral; all ages |
|
Zanamivir administration & age |
inhaled; >7yrs due to coordination required for administration |
|
Acyclovir/Penciclovir/Gancyclovir method of action |
Guanosine analog, terminates viral DNA replication |
|
Cidofovir method of action |
Cytosine analog, terminating viral DNA replication |
|
Acyclovir/Valacyclovir is best in which herpesviridae? |
HSV, VZV |
|
Gancyclovir is best for which herpesvirus? |
CMV |
|
Cidofovir is used for which herpesviridae? |
For strains resistant to Acyclovir/Penciclovir |
|
Side effects of Acyclovir/Vancyclovir |
well-tolerated; long course causes neutropenia; IV can cause nephrotoxicity |
|
Side effects of Gancyclovir/Valgancyclovir |
risk infections & IV injection site; bone marrow toxicity; CNS effects; teratogenic (do not use in pregnancy) |
|
Side effects of Cidofovir |
dose-dependent nephrotoxicity; neutropenia; carcinogenic; teratogenic |
|
Interferon-alpha method of action |
large glycoprotein/cytokine which boosts host antiviral response |
|
Ribaravin method of action |
Purine nucleoside analog, terminates viral DNA replication |
|
Anti-Hepatitis drugs |
IFN-alpha, ribaravin |
|
Adamantane/Amantadine method of action |
blocks M2 ion channel of influenza A to prevent viral uncoating (influenza B lacks the M2 target) |
|
Oseltamivir/Zanamivir method of action |
inhibit neuraminidase and prevent virion release from host cell, clumping virions together & preventing spread of infection |